
    
      The hypothesis is that genomic profiling measured by CancerSCAN, cfDNA, Whole exome
      sequencing (WES), Whole transcriptome sequencing (WTS), FACS(Fluorescence-Activated Cell
      Sorting), cytokine and immunologic signature analysis would be helpful to find out tolerance
      for chemotherapy and innovate new therapeutic strategies.
    
  